Sponsor List - 7th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference

7th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference

9th-10th March 2023 | ILEC Conference Centre & Ibis London Earls Court, London
Sponsors
Gold

Sengenics

Sengenics

Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision-making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, drug response prediction, and development of companion diagnostics.


Proteome Sciences

Proteome Sciences

We are a CRO specialising in the analysis of proteins and their associated PTM’s via advanced Mass Spectrometry.  By using proprietary methodologies, we can detect up to 8,000 proteins per sample in Discovery mode and can offer multiplexed assays of up to 100 proteins/sample in a GCLP accredited Targeted assay.

With their proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.

Silver

EpigenDx

EpigenDx

With over 15 years of experience in genetic and epigenetic clinical research, EpigenDx offers high quality products and laboratory services focused on DNA methylation analysis, gene expression profiling, and mutation analysis.  Our scientific teams carefully evaluate each project and establish analysis procedures using best fit technologies, including NGS, Pyrosequencing, RT-PCR, digital PCR, and GeneChip Microarray.  Our popular services include Line-1 global methylation tests and Foxp3-TSDR analysis for epigenetic immunotherapy.  Our GLP compliant and CLIA certified services make us the perfect partner during pre-clinical research and diagnostic test development.


BD Biosciences

BD Biosciences

Delivering innovative tools to basic and translational researchers. Our focus is directed towards advancing cellular analysis with flow cytometry cell analysers and sorters, fluorescently conjugated monoclonal antibodies as well as systems for single cell multiomics analysis. Bespoke antibody formulations, applications and assay design/development/optimization support as well as specific product training deliver holistic solutions to meet diverse customer needs.


Lunaphore Technologies

Lunaphore Technologies

Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology that can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. For further information on Lunaphore and its products, please visit www.lunaphore.com

Speaking Partner

TransCure bioServices

TransCure bioServices

TransCure bioServices (TCS) provides predictive in vivo pharmacology expertise for drug pre-clinical candidate selection in the fields of infectious, cancer (IO, PDX), inflammation, vaccine and immune disease areas. We are the only preclinical CRO providing commercially HIV, immuno-oncology (IO) therapy, PDX, IBD, vaccine and autoimmune mouse models with a fully functional reconstituted HUMAN IMMUNE SYSTEM (hu-mouse models). We co-design study protocols/experiments performing the ordered studies and providing comprehensive data collection, data analysis and reports.


Veracyte

Veracyte

Veracyte is a pioneering, global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions. Our growing menu of advanced diagnostic tests help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment. Veracyte offers customized multi-omics tools and expertise to our biopharmaceutical partners, helping them advance their therapeutic discovery, development and commercialization programs.

Exhibition Partner

Cureline

Cureline

Cureline, Inc. is a global contract research organization (CRO) and a commercial biobank supporting preclinical research in oncology, hematology, immune-oncology and various other therapeutic areas (Cardio-vascular, metabolic, neuro-degenerative, infectious and inherited conditions) to the pharmaceutical, biotechnology, and medical device industries worldwide since 2003.


Biognosys

Biognosys

At Biognosys, we believe that proteome insights unfold breakthrough discoveries that can dramatically improve human health. With our versatile portfolio of proprietary next-generation proteomics services, software, and kits, we provide a multi-dimensional view of protein expression, function, and structure in all sample types. Our patented technologies utilize high-resolution mass spectrometry, and through advanced data analytics, we translate data into actionable insights for R&D and clinical research.


Canopy Biosciences

Canopy Biosciences

Canopy Biosciences(r), a Bruker company, empowers innovation by providing access to cutting-edge spatial biology and multi-omic tools so biomedical researchers can drive scientific discovery faster. We offer instruments and services for spatial proteomics and transcriptomics, gene expression profiling, and CLIA services for IHC, FISH and histopathology. Learn more by visiting CanopyBiosciences.com.


PeproTech

PeproTech

PeproTech is a business unit within the Thermo Fisher Scientific Biosciences Division, specializing in manufacturing high quality cytokine products and providing exceptional service to the global life science and cell therapy markets. Our products include Recombinant Human, Murine and Rat Cytokines, Animal-Free Recombinant Cytokines, GMP Cytokines, Antibodies and ELISA Kits.

Meeting Partner

Talem Therapeutics

Talem Therapeutics

Talem Therapeutics is a biotherapeutic company and a wholly owned subsidiary of ImmunoPrecise Antibodies (IPA) that leverages IPA’s antibody discovery and development expertise combined with AI/bioinformatics to generate valuable assets (best-in-class / first-in-class) for out-licensing and co-development. Talem's experts focus on next generation antibodies from target validation through IND-Readiness (indication agnostic).